Nanotechnology-assisted lung cancer diagnosis: biomarkers and imaging
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Biosensors and Analytical Detection · Nanoplatforms for cancer theranostics · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Bica-Pop C et al (2018) Overview upon miR-21 in lung cancer: focus on NSCLC. Cell Mol Life Sci 75:3539–355110.1007/s00018-018-2877-x ↗
2. Bray F et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Clin 74(3):229–26310.3322/caac.21834 ↗
3. Chen S et al (2023) Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050. JAMA Oncol 9(4):465–47210.1001/jamaoncol.2022.7826 ↗
4. Perez-Warnisher MT, de Miguel MdPC, Seijo LM (2019) Tobacco use worldwide: legislative efforts to curb consumption. Ann Glob Health 85(1). https://doi.org/10.5334/aogh.241710.5334/aogh.2417 ↗
5. Gardner L et al (2022) Nano-omics: nanotechnology-based multidimensional harvesting of the blood-circulating cancerome. Nat Rev Clin Oncol 19(8):551–56110.1038/s41571-022-00645-x ↗
6. Inamura K (2017) Lung cancer: understanding its molecular pathology and the 2015 WHO classification. Front Oncol 7:19310.3389/fonc.2017.00193 ↗
7. Mottaghitalab F et al (2017) Targeted delivery system based on gemcitabine-loaded silk fibroin nanoparticles for lung cancer therapy. ACS Appl Mater Interfaces 9(37):31600–3161110.1021/acsami.7b10408 ↗
8. Moradi A et al (2024) Targeted delivery of doxorubicin by SP5-52 peptide conjugated exosome nanoparticles into lung tumor: an in vitro and in vivo study. J Drug Deliv Sci Technol 92:10531310.1016/j.jddst.2023.105313 ↗
9. Cryer AM, Thorley AJ (2019) Nanotechnology in the diagnosis and treatment of lung cancer. Pharmacol Ther 198:189–20510.1016/j.pharmthera.2019.02.010 ↗
10. Crosby D et al (2022) Early detection of cancer. Science 375(6586):eaay904010.1126/science.aay9040 ↗
11. Duma N, Santana-Davila R, Molina JR (2019) Non–small cell lung cancer: epidemiology, screening, diagnosis, and treatment. In Mayo Clinic Proceedings. Elsevier.10.1016/j.mayocp.2019.01.013 ↗
12. Oudkerk M et al (2017) European position statement on lung cancer screening. Lancet Oncol 18(12):e754–e76610.1016/S1470-2045(17)30861-6 ↗
13. Blandin Knight S et al (2017) Progress and prospects of early detection in lung cancer. Open Biol 7(9):17007010.1098/rsob.170070 ↗
14. Yazdi MK et al (2020) Controlled/localized release and nanotechnology. Nanoengineered biomaterials for advanced drug delivery. Elsevier, pp 27–3610.1016/B978-0-08-102985-5.00002-4 ↗
15. Mottaghitalab F et al (2019) New insights into designing hybrid nanoparticles for lung cancer: diagnosis and treatment. J Control Release 295:250–26710.1016/j.jconrel.2019.01.009 ↗
16. Zhang Y, Li M, Gao X, Chen Y, Liu T (2019) Nanotechnology in cancer diagnosis: progress, challenges and opportunities. J Hematol Oncol 12:1–13. https://doi.org/10.1186/s13045-019-0833-310.1186/s13045-019-0833-3 ↗
17. Peng G et al (2009) Diagnosing lung cancer in exhaled breath using gold nanoparticles. Nat Nanotechnol 4(10):669–67310.1038/nnano.2009.235 ↗
18. Yu MK et al (2008) Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo. Angew Chem Int Ed 47(29):5362–536510.1002/anie.200800857 ↗
19. Lin D et al (2021) Circulating tumor cells: Biology and clinical significance. Signal Transduct Target Ther 6(1):40410.1038/s41392-021-00817-8 ↗
20. Bach PB et al (2012) Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 307(22):2418–242910.1001/jama.2012.5521 ↗
21. Mukherjee A, Paul M, Mukherjee S (2019) Recent progress in the theranostics application of nanomedicine in lung cancer. Cancers 11(5):59710.3390/cancers11050597 ↗
22. Tang X et al (2020) Recent progress of lung cancer diagnosis using nanomaterials. Crystals 11(1):2410.3390/cryst11010024 ↗
23. Spiro SG, Gould MK, Colice GL (2007) Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes: ACCP evidenced-based clinical practice guidelines. Chest 132(3):149S-160S10.1378/chest.07-1358 ↗
24. Rivera MP, Mehta AC, Wahidi MM (2013) Establishing the diagnosis of lung cancer: diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143(5):e142S-e165S10.1378/chest.12-2353 ↗
25. Howington JA et al (2013) Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143(5):e278S-e313S10.1378/chest.12-2359 ↗
26. Gould MK et al (2013) Evaluation of individuals with pulmonary nodules: when is it lung cancer?: diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143(5):e93S-e120S10.1378/chest.12-2351 ↗
27. Hanna GB et al (2019) Accuracy and methodologic challenges of volatile organic compound–based exhaled breath tests for cancer diagnosis: a systematic review and meta-analysis. JAMA Oncol 5(1):e182815–e18281510.1001/jamaoncol.2018.2815 ↗
28. Nooreldeen R, Bach H (2021) Current and future development in lung cancer diagnosis. Int J Mol Sci 22(16):866110.3390/ijms22168661 ↗
29. Gallamini A, Zwarthoed C, Borra A (2014) Positron emission tomography (PET) in oncology. Cancers 6(4):1821–188910.3390/cancers6041821 ↗
30. Smith RA et al (2018) Cancer screening in the United States, 2018: a review of current American Cancer Society guidelines and current issues in cancer screening. CA: A Cancer J Clin 68(4):297–31610.3322/caac.21446 ↗
31. Tartarone A, Lerose R, Aieta M (2020) Focus on lung cancer screening. J Thorac Dis 12(7):381510.21037/jtd.2020.02.17 ↗
32. Chen K-N (2020) The diagnosis and treatment of lung cancer presented as ground-glass nodule. Gen Thorac Cardiovasc Surg 68:697–70210.1007/s11748-019-01267-4 ↗
33. Kauczor H-U et al (2020) ESR/ERS statement paper on lung cancer screening. Eur Radiol 30:3277–329410.1007/s00330-020-06727-7 ↗
34. Sieren JC et al (2010) Recent technological and application developments in computed tomography and magnetic resonance imaging for improved pulmonary nodule detection and lung cancer staging. J Magn Reson Imaging 32(6):1353–136910.1002/jmri.22383 ↗
35. Di Capua D et al (2021) The liquid biopsy for lung cancer: state of the art, limitations and future developments. Cancers 13(16):392310.3390/cancers13163923 ↗
36. Ostrin EJ et al (2020) Biomarkers for lung cancer screening and detection. Cancer Epidemiol Biomark Prev 29(12):2411–241510.1158/1055-9965.EPI-20-0865 ↗
37. Kim YJ et al (2024) Optical nanomaterial-based detection of biomarkers in liquid biopsy. J Hematol Oncol 17(1):1010.1186/s13045-024-01531-y ↗
38. Joshi S et al (2022) Simple diagnosis of cancer by detecting CEA and CYFRA 21–1 in saliva using electronic sensors. Sci Rep 12(1):1531510.1038/s41598-022-19593-8 ↗
39. Alarfaj NA, El-Tohamy MF, Oraby HF (2020) New immunosensing-fluorescence detection of tumor marker cytokeratin-19 fragment (CYFRA 21–1) via carbon quantum dots/zinc oxide nanocomposite. Nanoscale Res Lett 15:1–1410.1186/s11671-020-3247-9 ↗
40. Wojcik E, Kulpa JK (2017) Pro-gastrin-releasing peptide (ProGRP) as a biomarker in small-cell lung cancer diagnosis, monitoring and evaluation of treatment response. Lung Cancer: Targets and Therapy 8:231–240. https://doi.org/10.2147/LCTT.S14951610.2147/LCTT.S149516 ↗
41. Gao Y, Song P, Li H, Jia H, Zhang B (2017) Elevated serum CEA levels are associated with the explosive progression of lung adenocarcinoma harboring EGFR mutations. BMC Cancer 17:1–7. https://doi.org/10.1186/s12885-017-3474-310.1186/s12885-017-3474-3 ↗
42. Antonicelli A, Cafarotti S, Indini A, Galli A, Russo A, Cesario A, Lococo F, Russo P, Mainini AF, Bonifati LG, Nosotti M, Santambrogio L, Margaritora S, Granone P, Dutly AE (2013) EGFR-targeted therapy for non-small cell lung cancer: focus on EGFR oncogenic mutation. Int J Med Sci 10(3):320. https://doi.org/10.7150/ijms.460910.7150/ijms.4609 ↗
43. Riely GJ, Kris MG, Rosenbaum D, Marks J, Li A, Chitale DA, Nafa K, Riedel E, Hsu M, Pao W, Miller VA, Ladanyi M (2008) Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma. Clin Cancer Res 14(18):5731–5734. https://doi.org/10.1158/1078-0432.CCR-08-064610.1158/1078-0432.CCR-08-0646 ↗
44. Zheng W, Zhao J, Tao Y, Guo M, Ya Z, Chen C, Xu L et al (2018) MicroRNA-21: a promising biomarker for the prognosis and diagnosis of non-small cell lung cancer. Oncol lett 16(3):2777–2782. https://doi.org/10.3892/ol.2018.897210.3892/ol.2018.8972 ↗
45. Capuano R et al (2019) Sensors for lung cancer diagnosis. J Clin Med 8(2):23510.3390/jcm8020235 ↗
46. Nakhleh MK et al (2017) Diagnosis and classification of 17 diseases from 1404 subjects via pattern analysis of exhaled molecules. ACS Nano 11(1):112–12510.1021/acsnano.6b04930 ↗
47. Lee LJ et al (2016) Extracellular mRNA detected by tethered lipoplex nanoparticle biochip for lung adenocarcinoma detection. Am J Respir Crit Care Med 193(12):1431–143310.1164/rccm.201511-2129LE ↗
48. Cui X, Cheng W, Han X (2018) Lipid bilayer modified gold nanorod@ mesoporous silica nanoparticles for controlled drug delivery triggered by near-infrared light. J Mater Chem B 6(48):8078–808410.1039/C8TB01891J ↗
49. Cui X et al (2019) A multifunctional biomimetic hybrid nanocarrier for the controlled delivery of chemotherapy drugs by near-infrared light. New J Chem 43(6):2752–275710.1039/C8NJ05879B ↗
50. Yang C et al (2020) Phototherapy ablation of rabbit orthotopic tumors by non-stoichiometric BiPO4− x nanoparticles. Chem Eng J 386:12396110.1016/j.cej.2019.123961 ↗
51. Yilun W, Yaojing Z, Hongcan S (2024) Nanoparticle trends and hotspots in lung cancer diagnosis from 2006–2023: a bibliometric analysis. Front Oncol 14:145302110.3389/fonc.2024.1453021 ↗
52. Massion PP, Caprioli RM (2006) Proteomic strategies for the characterization and the early detection of lung cancer. J Thorac Oncol 1(9):1027–103910.1097/01243894-200611000-00019 ↗
53. Farka Z et al (2024) Nanoparticle-based bioaffinity assays: from the research laboratory to the market. Adv Mater 36(3):230765310.1002/adma.202307653 ↗
54. He A et al (2013) A novel immunoassay for the quantization of CYFRA 21–1 in human serum. J Clin Lab Anal 27(4):277–28310.1002/jcla.21597 ↗
55. Kimura A et al (2022) Targeted imaging of lung cancer with hyperpolarized 129Xe MRI using surface-modified iron oxide nanoparticles as molecular contrast agents. Cancers 14(24):607010.3390/cancers14246070 ↗
56. Zhou T et al (2020) Role of Gd2O3-doped carbon-11-choline-lenvatinib nanoparticles contrast agent PET/CT in the diagnosis of patients with lung cancer. Oncol Lett 19(2):1117–1124
57. Chinen AB et al (2015) Nanoparticle probes for the detection of cancer biomarkers, cells, and tissues by fluorescence. Chem Rev 115(19):10530–1057410.1021/acs.chemrev.5b00321 ↗
58. Kumar A, Mazinder Boruah B, Liang X-J (2011) Gold nanoparticles: promising nanomaterials for the diagnosis of cancer and HIV/AIDS. J Nanomater. https://doi.org/10.1155/2011/20218710.1155/2011/202187 ↗
59. Daniel M-C, Astruc D (2004) Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem Rev 104(1):293–34610.1021/cr030698+ ↗
60. Ho J-aA et al (2010) Diagnostic detection of human lung cancer-associated antigen using a gold nanoparticle-based electrochemical immunosensor. Anal Chem 82(14):5944–595010.1021/ac1001959 ↗
61. Levy R et al (2010) Gold nanoparticles delivery in mammalian live cells: a critical review. Nano reviews 1(1):488910.3402/nano.v1i0.4889 ↗
62. Bhattacharyya S et al (2011) Inorganic nanoparticles in cancer therapy. Pharm Res 28:237–25910.1007/s11095-010-0318-0 ↗
63. Yeh Y-C, Creran B, Rotello VM (2012) Gold nanoparticles: preparation, properties, and applications in bionanotechnology. Nanoscale 4(6):1871–188010.1039/C1NR11188D ↗
64. Akhter S et al (2012) Gold nanoparticles in theranostic oncology: current state-of-the-art. Expert Opin Drug Deliv 9(10):1225–124310.1517/17425247.2012.716824 ↗
65. Trono JD et al (2011) Size, concentration and incubation time dependence of gold nanoparticle uptake into pancreas cancer cells and its future application to X-ray drug delivery system. J Radiat Res 52(1):103–10910.1269/jrr.10068 ↗
66. Arnida M et al (2011) Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. Eur J Pharm Biopharm 77(3):417–42310.1016/j.ejpb.2010.11.010 ↗
67. Hainfeld J et al (2006) Gold nanoparticles: a new X-ray contrast agent. Br J Radiol 79(939):248–25310.1259/bjr/13169882 ↗
68. Reuveni T et al (2011) Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study. Int J Nanomedicine 2859–2864. https://doi.org/10.2147/IJN.S2544610.2147/IJN.S25446 ↗
69. Popovtzer R et al (2008) Targeted gold nanoparticles enable molecular CT imaging of cancer. Nano Lett 8(12):4593–459610.1021/nl8029114 ↗
70. Rostami A, Sazgarnia A (2019) Gold nanoparticles as cancer theranostic agents. Nanomed J 6(3):147–160. https://doi.org/10.22038/nmj.2019.06.0000110.22038/nmj.2019.06.00001 ↗
71. Taghavi H et al (2020) Comparison of gold nanoparticles and iodinated contrast media in radiation dose reduction and contrast enhancement in computed tomography. Iran J Radiol 17(1). https://doi.org/10.5812/iranjradiol.9244610.5812/iranjradiol.92446 ↗
72. You J et al (2022) Novel Detection Method for Circulating EGFR Tumor DNA Using Gravitationally Condensed Gold Nanoparticles and Catalytic Walker DNA. Materials 15(9):330110.3390/ma15093301 ↗
73. Linh ND et al (2023) Electrochemical interface based on polydopamine and gold nanoparticles/reduced graphene oxide for impedimetric detection of lung cancer cells. RSC Adv 13(15):10082–1008910.1039/D3RA00793F ↗
74. Zhou S et al (2020) A novel portable biosensor based on aptamer functionalized gold nanoparticles for adenosine detection. Anal Chim Acta 1120:43–4910.1016/j.aca.2020.04.046 ↗
75. Kuntamung K et al (2021) A label-free immunosensor for the detection of a new lung cancer biomarker, GM2 activator protein, using a phosphomolybdic acid/polyethyleneimine coated gold nanoparticle composite. Analyst 146(7):2203–221110.1039/D0AN02149K ↗
76. Shaffie A et al (2022) Lung cancer diagnosis system based on volatile organic compounds (VOCs) profile measured in exhaled breath. Appl Sci 12(14):716510.3390/app12147165 ↗
77. Gao W et al (2017) Highly sensitive detection of multiple tumor markers for lung cancer using gold nanoparticle probes and microarrays. Anal Chim Acta 958:77–8410.1016/j.aca.2016.12.016 ↗
78. Zheng X et al (2023) Metal nanoparticles as novel agents for lung cancer diagnosis and therapy. Small 19(18):220662410.1002/smll.202206624 ↗
79. Shandilya R et al (2021) Point-of-care diagnostics approaches for detection of lung cancer-associated circulating miRNAs. Drug Discov Today 26(6):1501–150910.1016/j.drudis.2021.02.023 ↗
80. Tan A et al (2011) Quantum dots and carbon nanotubes in oncology: a review on emerging theranostic applications in nanomedicine. Nanomedicine 6(6):1101–111410.2217/nnm.11.64 ↗
81. Medintz IL et al (2005) Quantum dot bioconjugates for imaging, labelling and sensing. Nat Mater 4(6):435–44610.1038/nmat1390 ↗
82. Chan WC, Nie S (1998) Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 281(5385):2016–201810.1126/science.281.5385.2016 ↗
83. Michalet X et al (2005) Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307(5709):538–54410.1126/science.1104274 ↗
84. Zhou M, Ghosh I (2007) Quantum dots and peptides: a bright future together. Peptide Science: Original Research on Biomolecules 88(3):325–33910.1002/bip.20655 ↗
85. Gao X et al (2004) In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 22(8):969–97610.1038/nbt994 ↗
86. Conjugates AD Highly Sensitive Single Domain.
87. Bethune G et al (2010) Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update. J Thorac Dis 2(1):48
88. Qu Y-G et al (2014) Quantum dots immunofluorescence histochemical detection of EGFR gene mutations in the non-small cell lung cancers using mutation-specific antibodies. Int J Nanomedicine 5771–5778.https://doi.org/10.2147/IJN.S7131010.2147/IJN.S71310 ↗
89. Liu L et al (2016) Bead-based microarray immunoassay for lung cancer biomarkers using quantum dots as labels. Biosens Bioelectron 80:300–30610.1016/j.bios.2016.01.084 ↗
90. Kumar P et al (2022) A review on advancements in carbon quantum dots and their application in photovoltaics. RSC Adv 12(8):4714–475910.1039/D1RA08452F ↗
91. Salvi A et al (2024) Biomedical application of cabon quantum dots: a review. Carbon Trends 100407. https://doi.org/10.1016/j.cartre.2024.10040710.1016/j.cartre.2024.100407 ↗
92. Kalkal A et al (2020) Biofunctionalized graphene quantum dots based fluorescent biosensor toward efficient detection of small cell lung cancer. ACS Appl Bio Mater 3(8):4922–493210.1021/acsabm.0c00427 ↗
93. El-Brolsy HMEM, Hanafy NA, El-Kemary MA (2022) Fighting non-small lung cancer cells using optimal functionalization of targeted carbon quantum dots derived from natural sources might provide potential therapeutic and cancer bio image strategies. Int J Mol Sci 23(21):1328310.3390/ijms232113283 ↗
94. Wang C et al (2020) Facile synthesis of novel carbon quantum dots from biomass waste for highly sensitive detection of iron ions. Mater Res Bull 124:11073010.1016/j.materresbull.2019.110730 ↗
95. Tian L et al (2021) Carbon quantum dots for advanced electrocatalysis. J Energy Chem 55:279–29410.1016/j.jechem.2020.06.057 ↗
96. Shi C et al (2019) N, S-self-doped carbon quantum dots from fungus fibers for sensing tetracyclines and for bioimaging cancer cells. Mater Sci Eng C 105:11013210.1016/j.msec.2019.110132 ↗
97. Su W et al (2020) Red-emissive carbon quantum dots for nuclear drug delivery in cancer stem cells. The journal of physical chemistry letters 11(4):1357–136310.1021/acs.jpclett.9b03891 ↗
98. Zhang M et al (2017) Near-infrared light triggered photo-therapy, in combination with chemotherapy using magnetofluorescent carbon quantum dots for effective cancer treating. Carbon 118:752–76410.1016/j.carbon.2017.03.085 ↗
99. Giordano MG et al (2023) An overview on carbon quantum dots optical and chemical features. Molecules 28(6):277210.3390/molecules28062772 ↗
100. Chousidis I, Stalikas CD, Leonardos ID (2020) Induced toxicity in early-life stage zebrafish (Danio rerio) and its behavioral analysis after exposure to non-doped, nitrogen-doped and nitrogen, sulfur-co doped carbon quantum dots. Environ Toxicol Pharmacol 79:10342610.1016/j.etap.2020.103426 ↗